Fresenius Medical Care (NYSE:FMS) Shares Gap Down - What's Next?

Fresenius Medical Care AG (NYSE:FMS - Get Free Report)'s share price gapped down prior to trading on Thursday . The stock had previously closed at $24.19, but opened at $23.35. Fresenius Medical Care shares last traded at $23.21, with a volume of 31,033 shares.

Analysts Set New Price Targets

Several research firms recently weighed in on FMS. Truist Financial increased their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a report on Monday, January 6th. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. Finally, Bank of America raised shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research note on Monday, December 2nd.

Fresenius Medical Care Price Performance

The stock has a 50 day moving average of $23.73 and a 200-day moving average of $22.28. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $14.54 billion, a P/E ratio of 20.48, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99.

Institutional Trading of Fresenius Medical Care

A number of large investors have recently made changes to their positions in the stock. Venturi Wealth Management LLC lifted its holdings in Fresenius Medical Care by 8.4% during the 4th quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock valued at $129,000 after buying an additional 441 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Fresenius Medical Care by 5.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock worth $210,000 after acquiring an additional 442 shares during the period. MML Investors Services LLC raised its stake in shares of Fresenius Medical Care by 5.3% during the third quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock valued at $320,000 after acquiring an additional 753 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after purchasing an additional 806 shares during the period. Finally, DAVENPORT & Co LLC grew its stake in Fresenius Medical Care by 1.5% in the fourth quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock worth $1,316,000 after purchasing an additional 862 shares in the last quarter. 8.37% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.